Edition:
India

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

4.60USD
9 Jul 2020
Change (% chg)

-- (--)
Prev Close
$4.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
285,186
52-wk High
$4.91
52-wk Low
$1.42

Select another date:

Wed, Jun 17 2020

BRIEF-Affimed NV Says Announced Completion Of First Dose Cohort In Phase 1/2A Clinical Trial Of AFM24

* AFFIMED NV - ANNOUNCED SUCCESSFUL COMPLETION OF FIRST DOSE COHORT IN PHASE 1/2A CLINICAL TRIAL OF AFM24 Source text for Eikon: Further company coverage:

BRIEF-Affimed Announces Appointment Of Angus Smith As Chief Financial Officer

* AFFIMED ANNOUNCES APPOINTMENT OF ANGUS SMITH AS CHIEF FINANCIAL OFFICER

BRIEF-Affimed Reports 2019 Financial Results And Recent Operational Progress

* AFFIMED REPORTS 2019 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS

BRIEF-Affimed NV Expects Coronavirus Pandemic To Impact Clinical Trials

* AFFIMED NV SAYS PROVIDES UPDATE ON OPERATIONS IN RESPONSE TO CONTINUED SPREAD OF COVID-19 CORONAVIRUS PANDEMIC

Select another date: